Skip to main content
. 2020 Dec 8;2020(12):MR000040. doi: 10.1002/14651858.MR000040.pub3

Xu 2017.

Study characteristics
Methods To examine the association between conflicts of interest and voting behaviour at the FDA advisory committee reports. Committee meetings on drugs and devices held between 2008 and 2014
Data 385 advisory committee reports
Comparisons Advisory committee members with financial conflicts of interest (defined as financial interests or personal and business relationships) and advisory committee members without financial conflicts of interest
Outcomes Recommendations (favourable recommendations defined as votes favourable to the product)
Funding source Funding source not described
Declaration of conflicts of interest The authors disclosed no conflicts of interest related any for‐profit company
Notes  
Risk of bias
Item Authors' judgement Support for judgement
Adequate document inclusion process Unclear Not possible to determine
Adequate coding of conflicts of interest Unclear Not possible to determine
Adequate coding of recommendations Unclear Not possible to determine
Adequate dealing with confounding No Compared advisory committee reports of different drugs and devices